Niagen Bioscience (NAGE) Current Leases (2011 - 2026)
Niagen Bioscience's (NAGE) quarterly Current Leases came in at $1.0 million in Q1 2026, up 11366.67% year-on-year from N/an in Q1 2025, and up 2.99% on a QoQ basis from $1.0 million in Q4 2025.
Niagen Bioscience (NAGE) Current Leases (2011 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 14 years of Current Leases data on file, last reported at $1.0 million in Q1 2026.
- On a quarterly basis, Current Leases rose 11366.67% year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was $1.0 million, a 11366.67% increase from a year earlier, with the FY2025 full-year figure at $1.0 million, up 8250.0% from the prior year.
- Current Leases for Q1 2026 stood at $1.0 million, up from $1.0 million in the prior quarter.
- Over the last five years, Current Leases for NAGE reached as high as $1.0 million in Q1 2026 and fell as low as $9000.0 in Q1 2025.
- Historically, Current Leases has averaged $369294.1 across 5 years, with a median of $17000.0 in 2022.
- Across the five-year window, Current Leases sank 98.59% in 2024 and surged 11366.67% in 2026, its largest moves.
- Year by year, Current Leases stood at $16000.0 in 2022, then plunged by 31.25% to $11000.0 in 2023, then gained by 9.09% to $12000.0 in 2024, then surged by 8250.0% to $1.0 million in 2025, then rose by 2.99% to $1.0 million in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $1.0 million in Q1 2026, $1.0 million in Q4 2025, and $976000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Niagen Bioscience | 253.47 Mn | 186.92 Mn | 19.98 Mn | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 976,000.00 |
| Jun 30, 2025 | 957,000.00 |
| Mar 31, 2025 | 9,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 11,000.00 |
| Sep 30, 2023 | 854,000.00 |
| Jun 30, 2023 | 10,000.00 |
| Mar 31, 2023 | 17,000.00 |
| Dec 31, 2022 | 16,000.00 |
| Sep 30, 2022 | 684,000.00 |
| Jun 30, 2022 | 646,000.00 |
| Mar 31, 2022 | 17,000.00 |
| Dec 31, 2021 | 528,000.00 |
| Sep 30, 2021 | 447,000.00 |
| Jun 30, 2021 | 467,000.00 |